Software as treatments

Our Mission

Deliver safe and effective digital treatments to patients in need

We develop, validate, and commercialize software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments.

Science of Change

We are committed to helping you live the life you want. That is why we are developing the science of change. Our digital therapeutics empower you to alter the underlying mechanisms of disease—to target the thoughts, sensations, emotions and behaviors that define the experience of your condition—to help you achieve a healthier, happier life.

Our Collaborators

Otsuka and Click Therapeutics Launch $300 Million Collaboration to Develop and Commercialize Digital Therapeutics for Patients with Major Depressive Disorder

Read More

Boehringer Ingelheim and Click Therapeutics Enter into $500 Million Collaboration to Develop and Commercialize CT-155, a Novel Prescription Digital Therapeutic to Aid in the Treatment of Schizophrenia

Read More

Magellan Health and Click Therapeutics Launch Fully Digital, Integrated and Comprehensive Smoking Cessation Program

Read More

Developing Software
As Treatments

We are a regulated Software as a Medical Device (SaMD)-focused biotechnology company that develops our applications as medical treatments in accordance with all relevant FDA, ISO and IEC standards.

01
Develop
We develop prescription software applications as medical devices that work independently or in conjunction with pharmacotherapies to treat disease.
02
Validate
We clinically validate these applications through rigorous randomized, controlled trials to demonstrate safety and efficacy.
03
Register
We seek FDA clearance for our apps as class II medical devices with independent therapeutic treatment claims or as adjuncts to existing therapy.
04
Commercialize
Physicians prescribe our apps and payers reimburse for them, while we generate and apply real world evidence to continuously personalize and improve the applications.

Leadership

David B. Klein
Chief Executive Officer
Randall Stanicky
Chief Financial Officer
Han Chiu
Chief Technology Officer
Austin C. Speier
Chief Strategy Officer
Shaheen Lakhan, MD, PhD, FAAN
Chief Medical Officer
Richard DeNunzio
Chief Commercial Officer
Tarique Collins
Chief Legal Officer
Shanna Milford
Chief People Officer

In The News

Contact us

Email us

Our offices
  • Headquarters
    80 White Street
    3rd Floor
    New York, NY 10013
  • 855 Boylston Street
    10th Floor
    Boston, MA 02116
  • 1111 Brickell Avenue
    10th Floor
    Miami, FL 33131
  • 1700 Montgomery Street
    Suite 108
    San Francisco, CA 94111